Leap Therapeutics (LPTX) Free Cash Flow (2013 - 2025)
Leap Therapeutics (LPTX) free cash flow from Mar 31, 2013 to Jun 30, 2025. The TTM Leap Therapeutics (LPTX) free cash flow is -$60M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Leap Therapeutics (LPTX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +20.02% |
| 3 Years TTM | +12.14% |
| 5 Years TTM | +17.85% |
| 10 Years TTM | +10.68% |
| All Time TTM | +16.03% |
Annual Free Cash Flow change of Leap Therapeutics (LPTX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$29M | -51.96% |
| 2024 | -$60M | +37.83% |
| 2023 | -$44M | -10.79% |
| 2022 | -$49M | +39.48% |
| 2021 | -$35M | +35.28% |
| 2020 | -$26M | -3.74% |
| 2019 | -$27M | +3.33% |
| 2018 | -$26M | +17.70% |
| 2017 | -$22M | -12.87% |
| 2016 | -$25M | +30.07% |
| 2015 | -$20M | +7.34% |
| 2014 | -$18M | +81.41% |
| 2013 | -$10M | +30.99% |
| 2012 | -$7.68M | N/A |